Memantine-induced Myoclonus in a Patient with Alzheimer Disease

  • Murgai A
  • LeDoux M
N/ACitations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

BACKGROUND: Myoclonus can be a clinical manifestation of numerous neurodegenerative disorders and an adverse drug reaction to medications used in their treatment. CASE REPORT: Herein, we report memantine-induced myoclonus in a patient with Alzheimer disease. The myoclonus seen in our patient was generalized (proximal limbs and trunk), present at rest and with action, and stimulus sensitive. A structured evaluation with the Unified Myoclonus Rating Scale showed that the myoclonus had no significant effect on functional capacity. After discontinuation of memantine, myoclonus slowly resolved over the course of several weeks. DISCUSSION: Memantine may cause myoclonus in susceptible individuals.

Cite

CITATION STYLE

APA

Murgai, A. A., & LeDoux, M. S. (2015). Memantine-induced Myoclonus in a Patient with Alzheimer Disease. Tremor and Other Hyperkinetic Movements, 5(0), 337. https://doi.org/10.5334/tohm.256

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free